Global X S&P Biotech ETF (cure) Logo

Global X S&P Biotech ETF (CURE)

___:___ · Financial Services
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

CURE ASX Chart

Snapshot

Global X S&P Biotech ETF (CURE, formerly ETFS S&P Biotech ETF) is an exchange traded fund that provides exposure to U.S. healthcare biotechnology companies. These companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -3.43%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,262 of 2,383
Sector Rank 434 of 608

Key Fundamentals

Shares Issued
Sector Financial Services
Similar Companies GOVT / KAT / EAS
EPS $0.00
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

CURE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Explore fund performance, fees, PDS and further insights for Global X S&P Biotech ETF (ASX:CURE) on Livewire.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Sydney NSW 2000
Website www.globalxetfs.com.au
Registry Computershare
Auditor KPMG
Date Listed -

Upcoming Calendar (Forecasted)

Date Event
19/09/2024 Report (Annual)

Former Company Names

  • ETFS S&P Biotech ETF (CURE), 19/09/2022

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
30/06/2022 $0.024 0% $0.024 Final 15/07/2022
30/06/2021 $6.2602 0% $6.2602 Final 15/07/2021
30/06/2020 $6.7562 0% $6.7562 Final 15/07/2020
28/06/2019 $1.1739 0% $1.1739 Interim 15/07/2019

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio 0%
DRP No
DRP Features -

Directors & Management

Directors

Management

Director Interests

The current holdings of CURE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Kim Young N/A N/A N/A N/A N/A
Evan Metcalf N/A N/A N/A N/A N/A
Oliver Reynolds N/A N/A N/A N/A N/A
Thomas (Tom) Park N/A N/A N/A N/A N/A

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $42.96 30 June
2022 $36.86 30 June
2021 $62.02 30 June
2020 $61.20 30 June
2019 $52.00 28 June
CURE Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.